Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzinova, Capricor, Grifols, Zealand.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Aptevo, Camurus, F2G, Galderma, Oncoinvent, Scholar Rock, Shionogi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Grail, Huxley Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acurx, Azitra, Immuneering, Lyell, Mineralys, Spyre, Ventyx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Prophase, Sacrix, Vizgen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Abelzeta, ADC, Akeso, Amplia, Ascentage, Astrazeneca, Biocryst, BMS, Brainstorm, Clarametyx, D&D, Eolo, Genmab, Halia, Incyte, Intellia, Janssen-Cilag, Jasper, Johnson, Kalvista, Lantern, Pharvaris, Regeneron, Roche, Sanofi, Sarepta, Tonix, Windtree, X4.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Everest, Immunewalk, Kelun-Biotech, Keymed Biosciences, Polypid, Samsung Bioepis.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Brainstorm, J&J.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astria, Beam, Bioarctic, Biorestorative, Celldex, Enliven, Incyte, Johnson& Johnson, Kancera, Keymed, Silence.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzinova, Angitia, Arthrosi, Biogen, Johnson & Johnson, Levicept, Merck, Novartis, Nurix , Samsung Bioepis, Sanofi, Schrödinger, Syndax, Third Harmonic, UCB.